1684-40-8
基本信息
塔克林
盐酸单满吖啶氨
盐酸他克林
1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE, MONOHYDROCHLORIDE
9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE
COGNEX
ROMOTAL
TACRINE
TACRINE HCL
TACRINE HYDROCHLORIDE
1,2,3,4-tetrahydro-9-acridinaminmonohydrochloride
1,2,3,4-tetrahydro-9-aminoacridinehydrochloride
1,2,3,4-tetrahydro-9-amino-acridinmonohydrochloride
9-amino-1,2,3,4-tetrahydro-acridinhydrochloride
ci970
hydroaminacrine
tacrinhydrochloride
tenakrin
tetrahydroaminacrin
1,2,3,4-tetrahydroacridin-9-amine monohydrochloride
9-AMINO-1,2,3,4-TETRAHYDROACRIDINEHYDROC HLORIDE HY
9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDRO -CHLORIDE (TACRINE, TH
物理化学性质
熔点 | 280-284 °C(lit.) |
储存条件 | 2-8°C |
溶解度 | 溶于水性缓冲液 |
酸度系数(pKa) | pKa 9.8 (Uncertain) |
形态 | 结晶固体 |
颜色 | White to light yellow |
CAS 数据库 | 1684-40-8(CAS DataBase Reference) |
EPA化学物质信息 | Tacrine hydrochloride (1684-40-8) |
安全数据
危险性符号(GHS) | GHS06 |
警示词 | 危险 |
危险性描述 | H302-H331-H301-H315-H319-H335 |
防范说明 | P305+P351+P338-P261-P280a-P304+P340-P405-P501a |
危险品标志 | T,Xn |
危险类别码 | R25-R36/37/38-R20/22 |
安全说明 | S26-S36-S45 |
危险品运输编号 | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS号 | AR9532500 |
危险等级 | 6.1(a) |
包装类别 | II |
毒性 | LD50 intravenous in mouse: 5600ug/kg |
图谱信息
四氢氨基吖啶(1684-40-8)质谱(MS)四氢氨基吖啶(1684-40-8)核磁图(1HNMR)四氢氨基吖啶(1684-40-8)核磁图(13CNMR)四氢氨基吖啶(1684-40-8)红外图谱(IR1)四氢氨基吖啶(1684-40-8)红外图谱(IR2)知名试剂公司产品信息
四氢氨基吖啶价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2024/11/08 | HY-111338 | 四氢氨基吖啶 Tacrine | 1684-40-8 | 5 mg | 800元 |
2024/11/08 | HY-B1488 | 四氢氨基吖啶 Tacrine hydrochloride | 1684-40-8 | 100mg | 600元 |
2024/11/08 | HY-111338 | 四氢氨基吖啶 Tacrine | 1684-40-8 | 10 mg | 1200元 |
常见问题列表
Target | Value |
BChE
(Cell-free assay) | 25.6 nM |
AChE
(Cell-free assay) | 31 nM |
Tacrine (12.5-37.5 nM) inhibits venom acetylcholinesterase as well as human serum butyrylcholinesterase in a concentration-dependent manner.
Tacrine reduces the neurotoxicity induced by the activation of the NMDARs in murine cortical neuronal cultures with an IC
50
of ~500 μM.
Tacrine inhibits the NMDAR responses in a concentration-dependent manner with an IC
50
of ~190 μM at -60 mV.
Tacrine (20-40 μmol/kg; s.c.) disrupts retention of learning in 17- and 30-day old mice in passive avoidance, and while the low dose of tacrine treatment (5 μmol/kg; s.c.) improves retention in 17-day old mice.
Tacrine (0.1-0.4 mg/mL; i.p. for 7 d) inhibits the expression of AChE, but does not significantly improve the protection of the retina function and morphology in mice.